ACCESS ACCUTNI+3 REAGENT A98264

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2020-03-03 for ACCESS ACCUTNI+3 REAGENT A98264 manufactured by Beckman Coulter.

Event Text Entries

[188140223] The full patient identifier for this report is case-(b)(6). The customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race. The device was not returned for evaluation. All assay and system verifications met specifications at the time of the event. No hardware errors, flags or other assay issues were reported in conjunction with the event. A beckman coulter (bec) field service engineer (fse) was dispatched in association with this event but did not identify a hardware, software or system issue that would have contributed to this event. In conclusion, the cause of this event cannot be determined with the available information.
Patient Sequence No: 1, Text Type: N, H10


[188140224] On february 21, 2020 the customer reported that a non-reproducible elevated access troponin i (access accutni+3) result of 0. 356 ng/ml was generated on the laboratory's dxi 800 immunoassay analyzer (part number a71456 and serial number (b)(4)) for one patient at approximately 06:30am. The initial elevated result was released from the laboratory. The customer reported that the physician questioned the result and the patient was redrawn; the redrawn sample was tested at 08:30am and a result of 0. 032 ng/ml was obtained. The customer also reported that the original sample was retested and a result of 0. 056 ng/ml was obtained. The customer did not provide reference ranges. The beckman coulter access accutni+3 reference range is 0. 00 - 0. 04 ng/ml. Customer reported treatment was provided to the patient but customer could not provide details of treatment administered. A written attempt was made to obtain additional information regarding treatment but to date no additional information has been received. Calibration, quality control and system check parameters were all recovering with expected ranges at the time of the event. Samples were collected in becton dickinson (bd)'s green top lithium heparin tubes. Samples were full draws. Customer stated the specimen was not hemolyzed and was clear. Customer also stated that the samples were centrifuged on the beckman automation line and customer did not know the centrifugation speed or time. No other sample processing or handling information was provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2122870-2020-00020
MDR Report Key9781097
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2020-03-03
Date of Report2020-03-03
Date of Event2020-02-21
Date Facility Aware2020-02-21
Date Mfgr Received2020-02-21
Device Manufacturer Date2019-11-01
Date Added to Maude2020-03-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. HARRY LONG
Manufacturer Street1000 LAKE HAZELTINE DRIVE M/S R590C
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal55318
Manufacturer Phone9523681224
Manufacturer G1BECKMAN COULTER
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACCESS ACCUTNI+3 REAGENT
Generic NameIMMUNOASSAY METHOD, TROPONIN SUBUNIT
Product CodeMMI
Date Received2020-03-03
Model NumberA98264
Catalog NumberA98264
Lot Number921318
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER
Manufacturer Address1000 LAKE HAZELTINE DRIVE CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.